REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

SBAL Po Onkologiya - Khaskovo EOOD (Bulgaria)

Main Activities: General Medical and Surgical Hospitals
Full name: Spetsializirana Bolnitsa Za Aktivno Lechenie Po Onkologiya - Khaskovo EOOD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

SBAL Po Onkologiya - Khaskovo EOOD is a company based in Bulgaria, with its head office in Haskovo. The company operates in the General Medical and Surgical Hospitals industry. SBAL Po Onkologiya - Khaskovo EOOD was incorporated on October 05, 2000. It currently has a total number of 95 (2023) employees. In 2021, the company reported a net sales revenue increase of 5.65%. Its’ total assets recorded a negative growth of 48.55%.

Headquarters
bul. Saedinenie 49
Haskovo; Haskovo; Postal Code: 6300

Contact Details: Purchase the SBAL Po Onkologiya - Khaskovo EOOD report to view the information.

Basic Information
Total Employees:
Purchase the SBAL Po Onkologiya - Khaskovo EOOD report to view the information.
Outstanding Shares:
Purchase the SBAL Po Onkologiya - Khaskovo EOOD report to view the information.
Registered Capital:
Purchase the SBAL Po Onkologiya - Khaskovo EOOD report to view the information.
Incorporation Date:
October 05, 2000
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after SBAL Po Onkologiya - Khaskovo EOOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
5.65%▲
Total operating revenue
14.48%▲
Operating profit (EBIT)
2557.14%▲
EBITDA
53.33%▲
Net Profit (Loss) for the Period
N/A
Total assets
-48.55%▼
Total equity
-80.47%▼
Operating Profit Margin (ROS)
1.85%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.02%▼
Cash Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo